Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DX25F6XUE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $77,370
Award facts
- Contract value 100% obligated
- $77,370.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $77,370.00 on September 22, 2025, for the supply of Xolair 150 mg/ml syringes. The contract is a firm fixed-price delivery order with an ultimate completion date of October 14, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency under the SPE2DB program, which is valued at approximately $500 million and extends through November 2026. The funding agency for this delivery order is the Medical Supply Chain, a defense-focused federal entity responsible for pharmaceutical procurement for military healthcare facilities.
Xolair is a biologic medication used primarily in the treatment of moderate-to-severe allergic asthma and chronic idiopathic urticaria, making this delivery order part of the broader pharmaceutical supply chain supporting Department of Defense medical facilities nationwide. DMS Pharmaceutical Group's role as a crucial supplier in the federal pharmaceutical distribution network enables the timely delivery of specialized biologic products to military health installations. The firm fixed-price structure ensures cost certainty for the government while the compressed timeline reflects the critical nature of pharmaceutical supply replenishment to support ongoing military healthcare operations.
Quick answers
Who was awarded contract SPE2DX25F6XUE?
SPE2DX25F6XUE was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 22, 2025.
How much is contract SPE2DX25F6XUE worth?
The government has obligated $77,370 on SPE2DX25F6XUE.
Is contract SPE2DX25F6XUE an order under another contract?
Yes. SPE2DX25F6XUE is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XUE competed?
The extent of competition for SPE2DX25F6XUE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award